tiprankstipranks
Hepion Pharmaceuticals (HEPA)
OTHER OTC:HEPA
US Market
HEPA
Hepion Pharmaceuticals
RESEARCH TOOLSreports
Want to see HEPA full AI Analyst Report?

Hepion Pharmaceuticals (HEPA) Income Statement

790 Followers

Hepion Pharmaceuticals Income Statement

Last quarter (Q4 2025), Hepion Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Hepion Pharmaceuticals's net income was $-656.88K. See Hepion Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 4.16M$ 19.35M$ 48.45M$ 45.49M$ 30.40M
Depreciation and Amortization
$ 0.00$ 30.76K$ 67.13K$ 77.46K$ 86.07K
EBITDA
$ -8.25M$ -14.88M$ -49.26M$ -45.00M$ -32.63M
Operating Income
$ -4.16M$ -19.35M$ -48.45M$ -45.49M$ -30.40M
Other Income/Expenses
$ -4.11M$ 3.18M$ -887.11K$ 404.83K$ -2.32M
Pretax Income
$ -8.28M$ -16.16M$ -49.34M$ -45.08M$ -32.72M
Net Income
$ -8.28M$ -13.19M$ -48.93M$ -42.20M$ -32.72M
Per Share Metrics
Basic EPS
$ -0.88$ -107.35$ -616.07$ -594.75$ -465.52
Diluted EPS
$ -0.88$ -107.35$ -616.07$ -594.75$ -465.52
Weighted Average Shares Outstanding
 9.41M 122.89K 79.42K 76.23K 70.29K
Weighted Average Shares Outstanding (Diluted)
 9.41M 122.89K 79.42K 76.23K 70.29K
Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History